Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 430
Summary
- Conditions
- Prostatic Neoplasms
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 80 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03119857
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Andreas Josefsson, PhD Univeristy of Gothenburg